Alexion Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Alexion Pharmaceuticals patents 15 in total
| Status | Patent |
|---|---|
Application | Utility: ALKALINE PHOSPHATASE POLYPEPTIDES AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: METHODS FOR TREATMENT OF REFRACTORY GENERALIZED MYASTHENIA GRAVIS WITH ECULIZUMAB Filling date: 26 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR PREPARING FACTOR XA AND DERIVATIVES Filling date: 26 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: METHODS FOR TREATING LYMPHOMA Filling date: 26 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: PROCESS FOR MAKING RECOMBINANT ANTIDOTE TO FACTOR XA INHIBITOR Filling date: 26 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: CERDULATINIB FOR THE TREATMENT OF B-CELL MALIGNANCIES Filling date: 26 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: METHODS FOR PREPARING AMMONIUM TETRATHIOMOLYBDATE Filling date: 26 Sep 2025 Issue date: 17 Mar 2022 |
Grant | Utility: Lysosomal acid lipase deficiency compositions and methods Filling date: 26 Sep 2025 Issue date: 1 Feb 2022 |
Application | Utility: FUSION PROTEINS AND METHODS OF TREATING COMPLEMENT DYSREGULATION USING THE SAME Filling date: 26 Sep 2025 Issue date: 13 Jan 2022 |
Application | Utility: METHODS FOR TREATMENT OF REFRACTORY GENERALIZED MYASTHENIA GRAVIS IN PEDIATRIC PATIENTS Filling date: 26 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: CO-ADMINISTRATION OF A HYALURONIDASE AND ANTI-C5 ANTIBODY FOR TREATMENT OF COMPLEMENT-ASSOCIATED CONDITIONS Filling date: 26 Sep 2025 Issue date: 16 Dec 2021 |
Application | Utility: ANTIDOTES TO FACTOR XA INHIBITORS Filling date: 26 Sep 2025 Issue date: 2 Dec 2021 |
Application | Utility: PREPARATION OF FACTOR XA DERIVATIVES Filling date: 26 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: METHODS FOR TREATMENT OF REFRACTORY GENERALIZED MYASTHENIA GRAVIS Filling date: 26 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: HUMANIZED ANTI-CD200 ANTIBODIES AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 29 Jul 2021 |
Showing 1 to 15 of 15 patents.